Authors: Watanabe J; Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Department of Immunology, Nagoya University Graduate School of Medicine, Aichi, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Shiozawa M; Division of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan., Ohori H; Division of Medical Oncology, Japanese Red Cross Ishinomaki Hospital, Miyagi, Japan., Takashima A; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yokota M; Department of General Surgery, Kurashiki Central Hospital, Okayama, Japan., Makiyama A; Department of Hematology/Oncology, Japan Community Healthcare Organization, Fukuoka, Japan., Akazawa N; Department of Gastrointestinal Surgery, Sendai City Medical Center, Sendai Open Hospital, Miyagi, Japan., Ojima H; Department of Gastroenterological Surgery, Gunma Prefectural Cancer Center, Gunma, Japan., Yuasa Y; Department of Gastroenterological Surgery, Japanese Red Cross Tokushima Hospital, Tokushima, Japan., Miwa K; Department of Cancer Multimodel Therapy Center, Kurume University Hospital, Fukuoka, Japan., Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Sato T; Research and Development Center for Medical Education, Department of Clinical Skills Education, Kitasato University School of Medicine, Sagamihara, Japan., Naitoh T; Department of Lower Gastrointestinal Surgery, Kitasato University School of Medicine, Sagamihara, Japan., Komatsu Y; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan., Kato T; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan., Hihara M; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Ltd, Tokyo, Japan., Soeda J; Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Ltd, Tokyo, Japan., Misumi T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Yamamoto K; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan., Akagi K; Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan., Ochiai A; Pathology Division, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.; now with the Research Institute for Biomedical Sciences, Tokyo University of Science, Tokyo, Japan., Uetake H; National Hospital Organization, Disaster Medical Center, Tokyo, Japan., Tsuchihara K; Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

Source: JAMA [JAMA] 2023 Apr 18; Vol. 329 (15), pp. 1271-1282.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Authors: Zhang J; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China., Xu L; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China., Hu H; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China., Chen E; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Cancer Center, Zhejiang University, Hangzhou, China.

Source: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 466-477.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE

Authors: Lee JH; Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea., Shin JY; Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea., Ahn J; Department of Ophthalmology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Source: Korean journal of ophthalmology : KJO [Korean J Ophthalmol] 2023 Apr; Vol. 37 (2), pp. 137-146. Date of Electronic Publication: 2023 Mar 23.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: KJO Country of Publication: Korea (South) NLM ID: 8804513 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-9382 (Electronic) Linking ISSN: 10118942 NLM ISO Abbreviation: Korean J Ophthalmol Subsets: MEDLINE

MeSH Terms: Bevacizumab*/therapeutic use , Dexamethasone*/therapeutic use , Diabetes Mellitus* , Macular Edema*/diagnosis , Macular Edema*/drug therapy , Macular Edema*/etiology, Humans ; Angiogenesis Inhibitors/therapeutic use ; Biomarkers ; Intravitreal Injections ; Retinal Detachment/drug therapy ; Retrospective Studies ; Tomography, Optical Coherence

Authors: Yap A; Department of Ophthalmology, The University of Auckland, 85 Park Road, Grafton, Auckland, 1051, New Zealand. aaron.yap8@gmail.com., Wang N; Department of Ophthalmology, The University of Auckland, 85 Park Road, Grafton, Auckland, 1051, New Zealand., Squirrell D; Department of Ophthalmology, The University of Auckland, 85 Park Road, Grafton, Auckland, 1051, New Zealand.; Department of Ophthalmology, Auckland District Health Board, Auckland, New Zealand.

Source: BMC ophthalmology [BMC Ophthalmol] 2022 Jul 28; Vol. 22 (1), pp. 325. Date of Electronic Publication: 2022 Jul 28.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

Authors: Sun JK; Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts., Beaulieu WT; Jaeb Center for Health Research, Tampa, Florida., Melia M; Jaeb Center for Health Research, Tampa, Florida., Ferris FL 3rd; Ophthalmic Research Consultants, LLC. Waxhaw, North Carolina., Maturi RK; Midwest Eye Institute, Indianapolis, Indiana.; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana., Nielsen JS; Wolfe Eye Clinic, Des Moines, Iowa., Solomon SD; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; and., Jampol LM; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois.

Corporate Authors: DRCR Retina Network

Source: Retina (Philadelphia, Pa.) [Retina] 2023 Apr 01; Vol. 43 (4), pp. 616-623.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

MeSH Terms: Macular Edema*/drug therapy , Diabetic Retinopathy*/drug therapy , Endothelial Growth Factors*/administration & dosage , Endothelial Growth Factors*/therapeutic use , Ranibizumab*/therapeutic use , Bevacizumab*/therapeutic use , Angiogenesis Inhibitors*/therapeutic use, Treatment Outcome

Authors: Zuo L; Department of Ophthalmology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, No. 1279, Sanmen road, Shanghai, 200434, China., Zhu S; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 85 / 86, Wujin road, Shanghai, 200080, China., Gu S; Department of Ophthalmology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, No. 1279, Sanmen road, Shanghai, 200434, China., Xu X; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 85 / 86, Wujin road, Shanghai, 200080, China. drxuxun@sjtu.edu.cn.

Source: BMC ophthalmology [BMC Ophthalmol] 2023 Apr 26; Vol. 23 (1), pp. 183. Date of Electronic Publication: 2023 Apr 26.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

Authors: LaFargue CJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Amero P; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Istituto di Endocrinologia ed Oncologia Sperimentale, CNR, Naples, Italy., Noh K; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Laboratory of Disease Modeling and Therapeutics, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea., Mangala LS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wen Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. ywen2@mdanderson.org., Bayraktar E; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Umamaheswaran S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Stur E; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Dasari SK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Ivan C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Pradeep S; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA., Yoo W; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lu C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Jennings NB; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Vathipadiekal V; Wave Life Sciences, 733 Concord Avenue, Cambridge, MA, 02138, USA.; Department of Genetic Medicines, Alloy Therapeutics, Waltham, USA., Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA., Chelariu-Raicu A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.; Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center, Munich, Germany., Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Deng H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Choi HJ; Department of Obstetrics and Gynecology, Chung-Ang University, College of Medicine, Seoul, Republic of Korea.; Department of Obstetrics and Gynecology, Chung-Ang University Gwangmyeong Hospital, College of Medicine Chung-Ang University, Seoul, South Korea., Hu M; CPRIT Single Core, Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kiyama T; Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, 77030, USA., Mao CA; Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, 77030, USA.; The MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA., Ali-Fehmi R; Department of Pathology, Wayne State University, Detroit, MI, 48201, USA., Birrer MJ; Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, Little Rock, AR, USA., Liu J; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Lopez-Berestein G; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., de Franciscis V; National Research Council (CNR), Institute of Genetic and Biomedical Research (IRGB)-UOS Milan via Rita Levi Montalcini, 20090, Pieve Emanuele, MI, Italy.; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA, 02115, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. asood@mdanderson.org.; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. asood@mdanderson.org.

Source: Nature communications [Nat Commun] 2023 Apr 26; Vol. 14 (1), pp. 2407. Date of Electronic Publication: 2023 Apr 26.

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Authors: Yumita S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan. ogasawaras@chiba-u.jp., Nakagawa M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Maruta S; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan., Okubo T; Department of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan., Itokawa N; Department of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan., Iino Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan.; Department of Gastroenterology, Kimitsu Chuo Hospital, Kisarazu, Japan., Obu M; Department of Gastroenterology, Kimitsu Chuo Hospital, Kisarazu, Japan., Haga Y; Department of Gastroenterology, National Hospital Organization Chiba Medical Center, Chiba, Japan., Seki A; Department of Gastroenterology, Funabashi Municipal Medical Center, Funabashi, Japan., Kogure T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Ishino T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Ogawa K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Fujiwara K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Iwanaga T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Fujita N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Sakuma T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kojima R; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kanzaki H; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Koroki K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Inoue M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kobayashi K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kiyono S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Nakamura M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kanogawa N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Saito T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kondo T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Nakagawa R; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Nakamoto S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Muroyama R; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Chiba T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan., Atsukawa M; Department of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan., Koma Y; Department of Gastroenterology, Kimitsu Chuo Hospital, Kisarazu, Japan., Azemoto R; Department of Gastroenterology, Kimitsu Chuo Hospital, Kisarazu, Japan., Ito K; Department of Gastroenterology, National Hospital Organization Chiba Medical Center, Chiba, Japan., Mizumoto H; Department of Gastroenterology, Funabashi Municipal Medical Center, Funabashi, Japan., Kato J; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan., Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, Japan.

Source: BMC gastroenterology [BMC Gastroenterol] 2023 Mar 31; Vol. 23 (1), pp. 101. Date of Electronic Publication: 2023 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

Authors: Wang H; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China. 18638561588@163.com., Xing R; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Li M; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Zhang M; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Wei C; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Zhang G; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Niu Y; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Ma Z; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China., Yan X; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, 450000, China.

Source: BMC cancer [BMC Cancer] 2023 Mar 30; Vol. 23 (1), pp. 289. Date of Electronic Publication: 2023 Mar 30.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Li S; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Yuan L; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Yue M; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China., Xu Y; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Liu S; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Wang F; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China., Liu X; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China., Wang F; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China., Deng J; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Sun Q; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Liu X; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Xue C; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Lu T; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Zhang W; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China.; Second Clinical School, Lanzhou University, Lanzhou, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China., Zhou J; Department of Radiology, Lanzhou University Second Hospital, Chengguan District, Cuiyingmen No.82, Lanzhou, 730030, China. ery_zhoujl@lzu.edu.cn.; Second Clinical School, Lanzhou University, Lanzhou, China. ery_zhoujl@lzu.edu.cn.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China. ery_zhoujl@lzu.edu.cn.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, China. ery_zhoujl@lzu.edu.cn.

Source: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2023 Mar 24; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2023 Mar 24.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

Authors: Liu Y; Department of Pharmacy, West China Second University Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.; Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China.; Department of Pharmacy, Pengzhou People's Hospital, Pengzhou, China., Dong C; Department of Pharmacy, Pengzhou People's Hospital, Pengzhou, China., He X; Department of Pharmacy, Pengzhou Second People's Hospital, Pengzhou, China., Wu P; Department of Pharmacy, Qionglai Maternal and Child Health and Family Planning Service Center, Qionglai, China., Shu Y; Department of Pharmacy, Tongji Hosiptal, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Chen L; Department of Pharmacy, West China Second University Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. chenl_hxey@scu.edu.cn.; Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. chenl_hxey@scu.edu.cn.; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China. chenl_hxey@scu.edu.cn.

Source: BMC nephrology [BMC Nephrol] 2023 Mar 10; Vol. 24 (1), pp. 51. Date of Electronic Publication: 2023 Mar 10.

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE

Authors: Matsubara Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. tmasuishi@aichi-cc.jp., Ogata T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Nakazawa T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Kato K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Nozawa K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Honda K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Bando H; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Ando M; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan., Tajika M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.

Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Mar; Vol. 149 (3), pp. 1123-1129. Date of Electronic Publication: 2022 Mar 22.

Publication Type: Clinical Trial; Comparative Study; Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Authors: Zeng H; Department of Interventional Radiology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Xu Q; Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Wang J; Medical Records and Statistics Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Xu X; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Luo J; Department of Interventional Radiology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Zhang L; Radiology Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Luo C; Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Ying J; Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Li J; Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

Source: Frontiers in immunology [Front Immunol] 2023 Jan 23; Vol. 14, pp. 1073133. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH Terms: Bevacizumab*/adverse effects , Bevacizumab*/therapeutic use , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/drug therapy , Tyrosine Protein Kinase Inhibitors*/administration & dosage , Tyrosine Protein Kinase Inhibitors*/therapeutic use, Humans ; B7-H1 Antigen/antagonists & inhibitors ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Retrospective Studies

Authors: Hanafy NAN; Institute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafrelsheikh 33516, Egypt., Eltonouby EAB; Department of Zoology, Research Laboratory of Molecular Carcinogenesis, Faculty of Science, Tanta University, Tanta 31527, Egypt., Salim EI; Department of Zoology, Research Laboratory of Molecular Carcinogenesis, Faculty of Science, Tanta University, Tanta 31527, Egypt., Mahfouz ME; Department of Zoology, Faculty of Science, Kafrelsheikh University, Kafrelsheikh 33516, Egypt., Leporatti S; CNR NANOTEC-Istituto di Nanotecnologia, Via Monteroni, 73100 Lecce, Italy., Hafez EH; Department of Zoology, Research Laboratory of Molecular Carcinogenesis, Faculty of Science, Tanta University, Tanta 31527, Egypt.

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 10; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 10.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Bevacizumab*/therapeutic use , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/metabolism , Hydrogels*/chemistry , Hydrogels*/therapeutic use , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Biological Products*/chemistry , Biological Products*/therapeutic use, Animals ; Angiogenesis Inhibitors/therapeutic use ; Bees/chemistry ; Bees/metabolism ; Lung Neoplasms/drug therapy ; Lung Neoplasms/metabolism ; Pollen/chemistry ; Pollen/metabolism ; Vascular Endothelial Growth Factor A/therapeutic use ; A549 Cells/drug effects ; A549 Cells/metabolism ; Nanoparticles/chemistry ; Nanoparticles/therapeutic use ; MCF-7 Cells/drug effects ; MCF-7 Cells/metabolism ; Humans

Authors: Margalit O; Sheba Medical Center, Ramat-Gan, Israel; Tel-Aviv University, Tel-Aviv, Israel. Electronic address: ofer.margalit@sheba.health.gov.il., Harmsen WS; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA., Shacham-Shmueli E; Sheba Medical Center, Ramat-Gan, Israel; Tel-Aviv University, Tel-Aviv, Israel., Voss MM; Department of Quantitative Science Research, Mayo Clinic, Scottsdale, AZ, USA., Boursi B; Sheba Medical Center, Ramat-Gan, Israel; Tel-Aviv University, Tel-Aviv, Israel., Wagner AD; Department of Oncology, Division of Medical Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Cohen R; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, F-75012 Paris, France; Sorbonne University, INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, F-75012 Paris, France., Olswold CL; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA., Saltz LB; Memorial Sloan Kettering Cancer Centre, New York, NY, USA., Goldstein DA; Rabin Medical Centre, Petach Tikvah, Israel., Hurwitz H; Duke Cancer Institute, Duke University, Durham, NC, USA., Tebbutt NC; University of Melbourne, Australia; Austin Health, Heidelberg, Victoria, Australia., Kabbinavar FF; David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, USA., Adams RA; Cardiff University and Velindre Cancer Centre, Cardiff, UK., Chibaudel B; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France., Grothey A; West Cancer Center, Germantown, TN, USA., Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Japan., Zalcberg J; Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia., de Gramont A; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France., Shi Q; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, USA., Lenz HJ; Department of Gastrointestinal Oncology, Keck School of Medicine at USC, Los Angeles, CA, USA.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jan; Vol. 178, pp. 162-170. Date of Electronic Publication: 2022 Nov 02.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

MeSH Terms: Bevacizumab*/therapeutic use , Colorectal Neoplasms*/drug therapy, Female ; Humans ; Male ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols ; Randomized Controlled Trials as Topic

Authors: Hui W; West China Hospital, Sichuan University, Chengdu, China., Song R; School of Public Health, China Medical University, Shenyang, China., Tao H; Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Gao Z; Department of Pharmacy, Affiliated Central Hospital of Shenyang Medical College, Shenyang, China., Zhu M; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, China., Zhang M; Department of Health Economics, School of Health Management, China Medical University, Shenyang, China., Wu H; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, China., Gong D; Medical Record Department, Xiamen Humanity Hospital, Xiamen, China., Zhang X; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, China., Cai Y; Department of Health Service Management, School of Health Management, China Medical University, Shenyang, China. yycai@cmu.edu.cn.

Source: BMC cancer [BMC Cancer] 2023 May 15; Vol. 23 (1), pp. 442. Date of Electronic Publication: 2023 May 15.

Publication Type: Meta-Analysis; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Liu T; Shandong University, Jinan, Shandong, China.; Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Wu S; Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China., Fang W; Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Li H; Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.; Department of Epidemiology and Health Statistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China., Su L; Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Qi G; Department of Medical Engineering Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Li H; Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China., Liu Y; Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Source: PloS one [PLoS One] 2023 Apr 18; Vol. 18 (4), pp. e0283719. Date of Electronic Publication: 2023 Apr 18 (Print Publication: 2023).

Publication Type: Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Wang L; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Peng Y; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Qin S; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Wan X; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Zeng X; PET-CT Center, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Li S; Faculty of Medicine, School of Health and Related Research, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom., Liu Q; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China., Tan C; Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Source: PloS one [PLoS One] 2023 Apr 13; Vol. 18 (4), pp. e0279786. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Zhou T; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China., Zhu S; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China., Xiong Q; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, Jiangxi Province, 330000, People's Republic of China., Gan J; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China., Wei J; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, Jiangxi Province, 330000, People's Republic of China., Cai J; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China. cjdl879@163.com.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, Jiangxi Province, 330000, People's Republic of China. cjdl879@163.com.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi Province, 330000, People's Republic of China. cjdl879@163.com., Liu A; Department of Oncology, The Second Affiliated Hospital of Nanchang University, No.1 Minde Street, Nanchang, Jiangxi Province, 330000, People's Republic of China. ndefy89028@ncu.edu.cn.; Jiangxi Key Laboratory of Clinical Translational Cancer Research, Nanchang, Jiangxi Province, 330000, People's Republic of China. ndefy89028@ncu.edu.cn.; Radiation Induced Heart Damage Institute of Nanchang University, Nanchang, Jiangxi Province, 330000, People's Republic of China. ndefy89028@ncu.edu.cn.

Source: BMC cancer [BMC Cancer] 2023 Apr 11; Vol. 23 (1), pp. 333. Date of Electronic Publication: 2023 Apr 11.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Authors: Xie D; Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Shi J; Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China., Zhou J; Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China.; Institute of Biomedical Sciences, Fudan University, Shanghai, China., Fan J; Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China.; Institute of Biomedical Sciences, Fudan University, Shanghai, China., Gao Q; Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai, China.

Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2023 Apr; Vol. 29 (2), pp. 206-216. Date of Electronic Publication: 2022 Dec 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE